1 篇报道
Supernus Pharmaceuticals Inc shares experienced a notable 5.2% surge to reach $39.84 during the trading session. The upward momentum comes despite a challenging yearly performance, though the company maintains a strong GF Score of 84 out of 100.
我们重视你的隐私. 我们使用必要的 Cookie 来保障网站运行；经你同意后，还会使用分析 Cookie 了解你的阅读偏好并改进网站。
